Skip to ContentSkip to Navigation
Rijksuniversiteit Groningenfounded in 1614  -  top 100 university
Over ons Praktische zaken Waar vindt u ons prof. dr. E.M.D. (Ed) Schuuring
University Medical Center Groningen

prof. dr. E.M.D. (Ed) Schuuring

Hoogleraar in de Moleculaire Oncologische Pathologie
Profielfoto van prof. dr. E.M.D. (Ed) Schuuring
E-mail:
e.schuuring umcg.nl

Publicaties

Corrigendum to "Regional differences in predictive biomarker testing rates for patients with metastatic NSCLC in the Netherlands" [Eur J Cancer 205 (2024)114125]

Radiotherapy Response Prediction in Myxofibrosarcomas and Undifferentiated Soft Tissue Sarcomas Using DNA Methylation and Copy Number Profiling

Trends in cervical cancer incidence in the Netherlands: A join-point and age–period–cohort analysis (1989–2023)

Authors' Reply “Non-Smoking and Non-Drinking Oral Cancer Patients Are at Higher Risk of Second Primary Tumours”

Cell-Free DNA Based Next-Generation Sequencing Does Not Differentiate Between Oligoprogression and Systemic Progression in Non-Small Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitors-An Explorative Study

Circulating Tumor DNA in Advanced EGFRex20+ NSCLC: Concordance with Tissue Biopsy, Monitoring of Response, and Resistance to High-Dose Osimertinib

Costs of biomarker testing in advanced non-small cell lung cancer: a global study comparing next-generation sequencing and single-gene testing

Detection of actionable mutations in circulating tumor DNA for non-small cell lung cancer patients

Distribution of Human Papillomavirus Genotypes in Real-World Cervical Self-Collected Scrapings From the Dutch Cervical Cancer Screening Program

Fostering the implementation of liquid biopsy in clinical practice: meeting report 2024 of the European Liquid Biopsy Society (ELBS)

Pers/media

Trouw Nieuwe test om baarmoederhalskanker op te sporen

Onderzoekers vinden nieuwe test om baarmoederhalskanker op te sporen: ‘Beter en vrouwvriendelijker’

Nieuwe Groningse test voorkomt duizenden fouten bij opsporen baarmoederhalskanker

European Liquid Biopsy Society geeft advies over de rapportage van ctDNA-testuitslagen

Highlights cfDNA

De praktische meerwaarde van de KNT-lijsten.

Delivering molecular pathology at lower costs

Dynamische lijsten voor testen op targets.

cieBOD adviseert over de primaire predictieve analyse van ctDNA in bloedplasma bij mNSCLC.